“Speaking truth to power”
- a Quaker maxim.
 
Top News arrow News / Infomails
News and Infomails from AHRP
Child’s Ordeal Shows Risks of Antipsychotic Drugs for Young PDF Print E-mail
Thursday, 02 September 2010
The prescribed drugs transformed Kyle Warren from a rambunctious healthy child into a drooling, sedated, obese, “shell.”
Read more...
 
Research Integrity: Don't Mess With the DSMB PDF Print E-mail
Monday, 30 August 2010

"The current way that DSMBs are constituted and report has resulted in a loss of faith." NEJM  

Read more...
 
Globalization of Pediatric Drug Trials--For Whose Benefit? PDF Print E-mail
Thursday, 26 August 2010

There is no evidence to indicate that children have been the beneficiaries of the Pediatric Exclusivity Provision of FDAMA (enacted in 1998): there is evidence that pharmaceutical companies have increased their profits from the legislation by at least $14 billion.  

Read more...
 
Making a Killing--Marketing Exercises by Dr. Carl Elliott PDF Print E-mail
Monday, 23 August 2010
The catalyst for Dr. Elliott's article was the tragic case of Dan Markingson, a 26-year old who committed suicide in May 2004, while enrolled in the CAFE trial, prescribed Seroquel. This case encapsulates the tragic consequences of a broken system which is not designed to detect the hazards for human subjects posed by market-driven research.
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 1 - 14 of 652
(C) 2010 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]